CHARLOTTE, N.C., June 19, 2014 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced the publication in Neurology of its pivotal, Phase 3 study 301, a...
-First Presentation of Integrated Data Analyses From Two Pivotal Trials -Data Shows Statistically Significant Improvement in Symptoms of NOH vs. Placebo CHARLOTTE, N.C. and STOCKHOLM...
CHARLOTTE, N.C., June 6, 2014 (GLOBE NEWSWIRE) -- Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust...
The Law Office of Robbins Arroyo LLP Announces Class Action Lawsuit Against Chelsea Therapeutics International, Ltd. PR Newswire SAN DIEGO and CHARLOTTE, N.C., June 2, 2014 SAN DIEGO and...
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board...
Acquisition Chelsea Therapeutics International, Ltd by H. Lundbeck A/S May Not Be in Shareholders' Best Interests PR Newswire SAN DIEGO and CHARLOTTE, N.C., May 12, 2014 SAN DIEGO and CHARLOTTE...
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Chelsea Therapeutics International, Ltd. (“Chelsea” or the...
Harwood Feffer LLP Announces Investigation of Chelsea Therapeutics International, Ltd. PR Newswire NEW YORK, May 9, 2014 NEW YORK, May 9, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com...
Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancorp, Inc., PokerTek, Inc., SP Bancorp, Inc. and 1st United Bancorp...
Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd. PR Newswire WAYNE, Pa., May 9, 2014 WAYNE, Pa., May 9, 2014 /PRNewswire/ -- Ryan & Maniskas, LLP is...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.